Atlas Trials

Study in HFpEF Patients to Compare the Effect of AZD9977 and Spironolactone on Serum Potassium

Clinical trial NCT03682497 · TERMINATED

Trial details

NCT number
NCT03682497
Sponsor
AstraZeneca
Status
TERMINATED
Phase
Phase 1
Study type
INTERVENTIONAL
Heart Failure
Start date
2018-11-01
Primary completion
2020-03-31
Enrollment
68

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.